UK markets closed

Calliditas Therapeutics AB (publ) (LC8.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
10.02-0.03 (-0.30%)
At close: 03:29PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-466,185
-466,185
-412,268
-500,293
-433,494
Depreciation & amortisation
48,726
48,726
12,913
34,433
2,823
Stock-based compensation
52,591
52,591
35,791
21,960
6,012
Change in working capital
-79,741
-79,741
88,420
5,470
54,083
Inventory
-16,781
-16,781
-2,758
-949
0
Other working capital
-447,443
-447,443
-313,866
-484,242
-309,181
Other non-cash items
-19,725
-19,725
15,902
4,428
-4
Net cash provided by operating activities
-434,655
-434,655
-311,354
-461,588
-309,181
Cash flows from investing activities
Investments in property, plant and equipment
-12,788
-12,788
-2,512
-22,654
-
Acquisitions, net
-
-
0
0
-172,602
Purchases of investments
-1,560
-1,560
-2,633
-1,686
-5
Sales/maturities of investments
602
602
0
0
-
Other investing activities
1
1
1
-24,340
-172,607
Net cash used for investing activities
-13,745
-13,745
-5,144
-24,340
-172,607
Cash flows from financing activities
Debt repayment
-736,613
-736,613
-9,615
-5,575
-3,972
Common stock issued
0
0
236
324,000
891,388
Common stock repurchased
0
0
-236
0
0
Other financing activities
-26,626
-26,626
-1,261
-82,787
-178,109
Net cash used provided by (used for) financing activities
199,651
199,651
575,991
435,161
768,558
Net change in cash
-248,750
-248,750
259,493
-50,766
286,770
Cash at beginning of period
1,249,094
1,249,094
955,507
996,304
753,540
Cash at end of period
973,733
973,733
1,249,094
955,507
996,304
Free cash flow
Operating cash flow
-434,655
-434,655
-311,354
-461,588
-309,181
Capital expenditure
-12,788
-12,788
-2,512
-22,654
-
Free cash flow
-447,443
-447,443
-313,866
-484,242
-309,181